TM
NMRD

Tiger Management’s Nemaura Medical, Inc. Common Stock NMRD Stock Holding History

Tiger Management’s Portfolio NMRD Stock Details NMRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-375,000
Closed -$336K – 33
2023
Q1 		$336K Hold
375,000
– – 0.18% 25
2022
Q4 		$644K Hold
375,000
– – 0.24% 27
2022
Q3 		$780K Hold
375,000
– – 0.34% 22
2022
Q2 		$964K Hold
375,000
– – 0.42% 11
2022
Q1 		$1.64M Buy
+375,000
New +$1.57M 0.27% 25

Other funds holding NMRD

Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
NA
NewEdge Advisors New Orleans, Louisiana $27.7B AUM 22.98% 1-Year Est. Return

Tiger Management's NMRD Position: Q2 2023 in Review

Tiger Management sold out of Nemaura Medical, Inc. Common Stock (NMRD) in Q2 2023, closing a stake of 375,000 shares — an estimated $336K sold.

Tiger Management first reported a position in NMRD in Q1 2022 and held it in 5 quarters. The position peaked at $1.64M in Q1 2022. 15 funds tracked by Wall St. Rank hold NMRD as of Q2 2023.

  • Tiger Management reported no remaining Nemaura Medical, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Tiger Management sold 375,000 Nemaura Medical, Inc. Common Stock shares in Q2 2023, an estimated $336K.
  • Tiger Management first reported a position in Nemaura Medical, Inc. Common Stock in Q1 2022 and held it in 5 quarters.
  • Tiger Management's Nemaura Medical, Inc. Common Stock position peaked at $1.64M in Q1 2022.
  • 15 funds tracked by Wall St. Rank held Nemaura Medical, Inc. Common Stock as of Q2 2023.

Based on Tiger Management's 13F filing for Q2 2023.